LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and other major Asian markets through partnerships that provide access to innovative therapeutic discoveries.
Show more
Show less
Investor insights
Funding rounds participated in
$310M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2019
Funding rounds raised
Total raised
$310M
from 3 investors over 1 rounds
L
LianBio raised $310M on November 29, 2020
Investors: CMG-SDIC Capital Management, RA Capital Management and + 13 Other investors